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ABSTRACT
Y chromosome microdeletions have been reported as a possible
genetic factor of male infertility. Despite a large number of studies in
this subject, there is still considerable debate and confusion sur-
rounding the role of Y chromosome microdeletions in male infertility.
This has been further compounded by observations of Y microdele-
tions in fertile males. The aim of the present study was to evaluate:
1) the incidence of Y microdeletions in control male population and
infertile males, where complete semen and hormonal analysis was
available to define whether Y microdeletions are specific for sper-
matogenic failure or if they can be found also in normospermic men;
and 2) whether the suboptimal semen quality reported in Denmark
is associated with a higher incidence of Y microdeletions in respect to
other populations. Double-blind molecular study of deletions was
performed in 138 consecutive patients seeking intracytoplasmic
sperm injection treatment, 100 men of known fertility, and 107 young
military conscripts from the general Danish population. Microdele-
tions or gene-specific deletions were not detected in normospermic
subjects or in subfertile men with a sperm count of more than 1 3
106/mL. Deletions of the Azoospermia factor (AZF)c region were de-
tected in 17% of individuals with idiopathic azoo/cryptozoospermia
and in 7% of individuals with nonidiopathic azoo/cryptozoospermia.
The data indicate that: 1) the composition of the study population is
the major factor in determining deletion frequency; 2) Y chromosome
microdeletions are specifically associated with severe spermatogenic
failure; therefore, the protocol described here is reliable for the rou-
tine clinical workup of severe male factor infertility; and 3) the fre-
quency of Yq microdeletions in the Danish population is similar to
that from other countries and argues against the involvement of
microdeletions in the relatively low sperm count of the Danish pop-
ulation. (J Clin Endocrinol Metab 86: 2638–2642, 2001)
RECENTLY, CONSIDERABLE attention has focused onthe role of genetic factors in spermatogenic failure (1),
with an emphasis on the Y chromosome. Deletions of three
nonoverlapping regions of the Y chromosome long arm have
been described, associated with male infertility. Deletions of
the AZFa region are mainly associated with Sertoli cell only
syndrome (SCOS), deletions of the AZFb region are mainly
associated with spermatogenic arrest, and a range of phe-
notypes from azoospermia to oligozoospermia are associated
with the absence of the AZFc region (2).
Individuals defined as idiopathic severe oligo- or
azoospermic have the highest frequency of Y microdeletions,
particularly involving the AZFc region. However, there re-
mains considerable debate concerning the frequency, the
position, and the phenotypes associated with Y chromosome
microdeletions. For example, deletion frequency has been
reported between 1–55% in different studies (3). It is not clear
whether these wide variations, particularly in deletion fre-
quency, are attributable to differences in the study design,
the geographic or ethnic origins of the study population, or
to experimental error. In addition, the contribution of Y mi-
crodeletions to male subfertility in the general population
has not been evaluated; and the incidence of Y microdele-
tions in control males, where complete semen and hormonal
analysis is available, has not been investigated. A complete
investigation of the latter group is necessary because Y mi-
crodeletions have been repeatedly reported in fertile men (2,
4–6), which suggests that microdeletions may not be con-
fined to infertile subjects. Until these questions have been
definitively resolved, the utility of Y chromosome microde-
letion screens in a clinical context remains controversial.
Here, for the first time, we describe a Yq microdeletion
screen of infertile, subfertile, and normospermic men from
the Danish population, where complete semen analysis and
hormonal profile was available. The DNA samples were
analyzed in a double-blind manner using 14 anonymous and
6 gene-specific Y chromosome markers. The choice of Danish
subjects for this study was not completely coincidental. A
recent study demonstrated that a relatively large fraction of
the otherwise healthy Danish male population seems to have
suboptimal semen quality (7). Thus, an additional aim of this
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study was to investigate a possible contribution of Y mi-
crodeletions to this worrying phenomenon. We show that Y
chromosome microdeletions are specific for spermatogenic
failure, that the variation in deletion frequency reported in
other studies is probable attributable to study design, and
that Y microdeletions do not seem to contribute to the rel-
atively low sperm count of the general Danish population.
Materials and Methods
The study population has been recruited and studied through a
comprehensive andrological examination, including semen analysis and
hormonal analysis by the Department of Growth and Reproduction
(Rigshospitalet, Copenhagen, Denmark). Samples were analyzed in a
double-blind manner. DNA samples were sent from the Department of
Growth and Reproduction in a coded way to the laboratory of Immu-
noge´ne´tique Humain (Institut Pasteur, Paris, France), where Y chromo-
some screening was performed. No exchange of information concerning
clinical or molecular data took place until the completion of the study.
Subjects
A total of 345 subjects were studied. These consisted of 138 consec-
utive patients seeking intracytoplasmic sperm injection (ICSI) treatment,
who were referred to the Rigshospitalet for a full andrological workup;
100 men of known fertility recruited from a Danish obstetric clinic who
recently made their partners pregnant; and 107 young military con-
scripts from the general Danish population. All subjects gave an in-
formed consent for molecular analysis of their blood samples, and the
study was approved by a local ethical committee. A subdivision of the
whole study population, on the basis of the sperm count, is shown in
Table 1. Among patients seeking ICSI treatment, 62 were affected by
idiopathic infertility; whereas, in 61 cases, abnormal andrological find-
ings (including cryptorchidism and .2 degree varicocele) were report-
ed; 12 patients were normozoospermic; and for 3 patients, no clinical
information, other than infertility possibly due to a male factor, was
available (Table 2).
Semen and hormonal analysis
Semen analysis was performed accordingly to the WHO 1992 guide-
lines (8). Serum concentrations of FSH, LH, and sex hormone binding
globulin were measured using time-resolved immunofluorometric as-
says from DELFIA, Wallac, Inc., Turku, FIN. Testosterone and estradiol
were measured by RIA (Coat-a-Count, Diagnostic Products, Los Ange-
les, CA) and Immuno, Diagostic Systems Laboratories, Inc. (Boldon,
UK), respectively. Serum inhibin B was measured in duplicate in a
double-antibody enzyme immunometric assay using a monoclonal an-
tibody raised against the inhibin bB-subunit in combination with a
labeled antibody raised against the inhibin a-subunit, as previously
described.
Molecular analysis
PCR analysis of genomic DNA, extracted from lymphocytes, was
performed. A total of 14 anonymous STS markers and 6 Y-specific genes,
spanning the 3 AZF regions, were screened [in AZFa: sY82, sY86, sY87,
and the gene DBY; in AZFb: sY114, sY116, sY125, sY133, and the genes
eIF-1AY, XKRY, and CDY; in AZFc: sY145, sY147, sY152, sY158, and the
genes BPY2 and DAZ (sY254)]. sY98 and sY100 (between AZFa and
AZFb) and sY160 (distal to AZFc in the heterochromatin) were also
included (Fig. 1). The PCR primers and conditions were described pre-
viously, with modifications (9, 10). Duplex amplifications were per-
formed using the following combinations: Mix A sY254, sY125; Mix 2
sY98 and sY100; Mix 3 sY160 and sY145; mix 4 sY87 and sY152. For each
duplex reaction, the PCR conditions were 95 C for 5 min, followed by
35 cycles of 95 C for 1 min, 60 C for 1 min, and 72 C for 1 min.
The presence of deletions was confirmed by Southern blotting using
a DAZ gene probe, as described elsewhere (10).
Results
Microdeletions were detected in nine infertile subjects af-
fected by azoospermia and cryptozoospermia (,1 3 106/
mL; six and three patients, respectively). The deletions re-
moved the entire AZFc region (sY145, sY147, sY152, and
sY158, including the genes DAZ and BPY2) in each case. No
difference in the extent of the deletion was detected. The
clinical details of each patient with an AZFc deletion are
described in Table 3. Microdeletions were not detected in the
group of oligozoospermic (.1 3 106/mL) or normospermic
subjects.
The frequency of Y microdeletions in the subgroups with
different sperm count shows the highest value among azoo/
cryptozoospermic men (nine cases, 11.5%). This percentage
has progressively decreased if severe oligozoospermic (8.9%)
TABLE 1. Subdivision of the whole study population on the basis of sperm count
Category
Sperm count
Azoospermia ,1 3 106/mL 1–5 3 106/mL 5–20 3 106/mL .20 3 106/mL
ICSI candidates 27 51 23 25 12
-with Yq deletion 6 3
Military conscripts 1 5 16 83a
Fertile men 2 8 89
Total number 27 52 30 49 184
Deletion 11.5%
frequency 8.9%
7.1%
Deletion frequencies are indicated as a percentage of those individuals with different degrees of spermatogenic failure. Deletion frequency
of 11.5%, 8.9%, and 7.1% in the subgroups of individuals with sperm count ,1 3 106/mL, ,5 3 106/mL, ,20 3 106/mL, respectively.
a Thirty-two military conscripts presented a sperm count of ,40 3 106/mL. A total of 53/105 (51%) of military conscripts have a sperm count
,40 3 106/mL.
OOOO
OOOOOOOOOOO
OOOOOOOOOOOOOOOOO
TABLE 2. Subdivision of the ICSI candidate’s group on the basis
of their sperm count and aetiology deletion frequencies are
calculated for the subgroups and for the overall study population
Category Idiopathic Nonidiopathic
Azoospermic 12 14
-With Yq deletion 4 2
,1 3 106/mL 23 27
-With Yq deletion 2 1
Subtotal (deletion
frequency)
35 (6/35; 17%) 41 (3/41; 7.3%)
1–5 3 106/mL 15 7
5–20 3 106/mL 12 13
Total (deletion frequency) 62 (6/62; 9.6%) 61 (3/61; 4.9%)
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and oligozoospermic subjects (7.1%) are included (Table 1).
Microdeletions were only observed in the subgroup of men
seeking ICSI treatment. Within this subgroup, the incidence
of microdeletions in idiopathic azoo/cryptozoospermic men
was 17% (Table 2). Microdeletions were also found in three
cases of nonidiopathic infertility (7%). These subjects pre-
sented with unilateral cryptorchidism, varicocele grade 2,
and hypoandrogenism with sexual dysfunction. In the first
two of these three cases, gonadal histology was available,
FIG. 1. Schematic representation of the long arm of the Y chromo-
some, divided into seven deletion intervals. The position of genes
identified on Yq are shown, as are the relative positions of the AZF
regions and the markers and genes used in this study.
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which revealed both spermatogenic arrest and SCOS. These
observations are consistent with the pattern of histology
associated with Y chromosome microdeletions. Isolated
gene-specific deletions were not detected. Although all the
microdeletions seemed to have the same molecular extent in
each case, a genotype/phenotype correlation could not be
established on the basis of the semen analysis and testicular
histology. Sperm concentration ranged from 0–0.135 3 106/
mL. Testicular histology varied from spermatocytic arrest
combined with Sertoli cell only (SCO) pattern to bilateral
SCO pattern combined with diffused Leydig cell hyperpla-
sia. The hormonal parameters showed a more homogeneous
picture: serum inhibin B levels were below the normal range
in each patient, whereas FSH levels were above the mean
(3.94 U/L) in all cases, with abnormally high values in seven
of nine patients.
Discussion
The data presented here clearly show that the composition
of the study population is a major factor influencing deletion
frequency. Patients affected by idiopathic infertility and se-
vere oligo- or azoospermia have a greater probability of
harboring microdeletions, compared with the nonidiopathic
group or moderate oligospermic men, respectively. We
found that the highest deletion frequency in the group de-
fined as idiopathic azoospermic/cryptozoospermic was 17%
(Table 2). A subdivision of the study population, on the basis
of sperm number, indicates a deletion frequency of 11.5% in
the group of azoospermic/cryptozoospermic patients (this
includes both idiopathic and nonidiopathic patients). The
incidence progressively decreases with the inclusion of less
severe phenotypes, to 8.9% (oligospermic with ,5 3 106
sperm per mL) and 7.1% (oligospermic with ,20 3 106 sperm
per mL) (Table 1). These figures are consistent with two other
studies of the French and Italian populations, where uni-
formly defined clinical groups were studied using a similar
study protocol (Refs. 9 and 10; Fig. 2). This suggests that
variation in deletion frequency is mainly attributable to the
clinical composition of the study group; and it also indicates
that, at least in Europe, there is no evidence to support a
variation in deletion frequency between different popula-
tions/ethnic groups or different geographic regions.
The data indicate a strict correlation between spermato-
genic failure and the presence of Y microdeletions. Deletions
were not detected in normospermic men, using the markers
developed in the current study. In the group of fertile males,
10 subjects presented with reduced sperm counts. Yq mi-
crodeletions have been previously reported in some studies
of fertile males (2, 4, 6). Because semen data for these men
was not available, these microdeletions may have been as-
sociated with subnormal sperm count, or the markers used
in the screening protocol may have been polymorphic.
All deletions detected in the current study involved the
AZFc region, and the associated phenotype ranged from
azoospermia to cryptozoospermia. This supports previous
observations that AZFc deletions are the most frequent, and
they are associated with a variable phenotype (3, 11). Because
serum inhibin B concentrations were uniformly very low in
the deleted patients, it is recommended that abnormally low
levels of inhibin B should be included among the indications
for a Y-chromosome-microdeletion screen. Gene-specific de-
letions were not detected, indicating that such events, which
FIG. 2. Schematic representation of the results of the current study and those reported for the French (10) and Italian populations (9), using
a similar set of markers and identical clinical definitions. The deletion frequency of the total study population and the deletion frequency of
the subgroup comprising idiopathic azoospermia and severe oligozoospermia are indicated. 1, Azoospermia; 2, normospermia; 3, asthenozo-
ospermia; 4, oligozoospermia (5–20 million/mL); 5, severe oligozoospermia (,5 million/mL).
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have been recently reported (12), are either rare or associated
with a well-defined clinical subgroup of patients. The use of
a PCR-based deletion detection method, such as that used in
this study, does not formally exclude other rearrangements
of the Y chromosome, such as reduction in gene copy num-
bers or other structural rearrangements of the Y chromosome
(inversions, duplications, and others) that may lead to male
subfertility.
In this study, three men defined as nonidiopathic infertile
(presenting cryptorchidism, varicocele, and hypoandro-
genism) were found to harbor microdeletions of the AZFc
region. The extent of these three deletions was identical to
that observed in the idiopathic infertile men. Though it is
possible that other factors could have contributed to reduced
sperm production, the gonad histology in two of these cases
was consistent with previous histological findings in cases
where Y microdeletions have been detected. Microdeletions
have occasionally been reported together with cryptorchid-
ism, varicocele, obstructive azoospermia, and hypogonado-
trophic hypogonadism (10, 11, 13) and are considered to be
chance association. This finding indicates that Y microdele-
tion screening has to be extended to all patients affected by
severe oligozoospermia, regardless of the presence of abnor-
mal andrological findings.
Several reports indicated that male sperm counts have
declined during the last 40–50 yr (14–16). This decline is
associated with an increase in the frequency of anomalies of
the male reproductive system, including ambiguous genita-
lia and testicular cancer. These data and the association be-
tween male subfertility and subsequent high risk of testicular
cancer are consistent with the hypothesis that male subfer-
tility and testicular cancer share important aethiological fac-
tors (17). Recently, a high frequency of young men with
suboptimal semen quality has been reported in Denmark
(18). More than 40% of young adult Danish men have sperm
counts below 40 3 106/mL, which, according to a recent
study (7), is associated with decreased fertility. Although a
number of factors (such as pesticides, exogenous estrogens,
and heavy metals) may have a negative impact on spermat-
ogenesis, none of these factors have been formally demon-
strated to be responsible for the reported decline in sperm
quality in some countries, including Denmark.
Although Y microdeletions of specific regions on the long
arm are a cause of male infertility, the data in this report
argues against the involvement of microdeletions in the re-
cently observed high incidence of reproductive abnormali-
ties, including relatively low sperm count of the Danish
population. The role of nongenetic factors, such as environ-
mental pollutants, needs to be further investigated. The data
also shows that the marker set used in the study is specific
for reduced sperm production and can therefore be used in
the routine clinical workup of both idiopathic and nonidio-
pathic severe oligozoospermic and azoospermic men. The
demonstration of a Y chromosome microdeletion in an in-
fertile man is not only important in defining the etiology of
the condition but is also of clinical prognostic value (19).
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